ENZC (Enzolytics) Other Stockholders Equity: $-0.00 Mil (As of Jun. 2011)


What is Enzolytics Other Stockholders Equity?

Enzolytics ENZC Other Stockholders Equity is $-0.00 Mil as of Jun. 2011.

Enzolytics's Other Stockholders Equity for the quarter that ended in Jun. 2011 was $-0.00 Mil.

Enzolytics's quarterly Other Stockholders Equity increased from Dec. 2010 ($-0.00 Mil) to Mar. 2011 ($0.00 Mil) but then declined from Mar. 2011 ($0.00 Mil) to Jun. 2011 ($-0.00 Mil).

Enzolytics's annual Other Stockholders Equity declined from Jul. 2008 ($0.00 Mil) to Dec. 2009 ($0.00 Mil) and declined from Dec. 2009 ($0.00 Mil) to Dec. 2010 ($-0.00 Mil).

Enzolytics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Enzolytics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics Other Stockholders Equity Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
Other Stockholders Equity
-0.06 0.00 0.00 -0.00

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 0.00 -0.00

Enzolytics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Enzolytics (ENZC) has a Other Stockholders Equity of $-0.00 Mil as of Jun. 2011. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Enzolytics and its competitors.
Is Enzolytics' Other Stockholders Equity too high?
Enzolytics' current Other Stockholders Equity is $-0.00 Mil.
How does Enzolytics' Other Stockholders Equity compare to competitors?
Enzolytics' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Enzolytics and its competitors. Enzolytics's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Enzolytics (ENZC), the current Other Stockholders Equity is $-0.00 Mil as of Jun. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.